BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16387087)

  • 1. Steroid-free tacrolimus monotherapy after pretransplantation thymoglobulin or Campath and laparoscopy in living donor renal transplantation.
    Tan HP; Kaczorowski D; Basu A; McCauley J; Marcos A; Donaldson J; Unruh M; Randhawa P; Zeevi A; Shapiro R
    Transplant Proc; 2005 Dec; 37(10):4235-40. PubMed ID: 16387087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience.
    Tan HP; Donaldson J; Ellis D; Moritz ML; Basu A; Morgan C; Vats AN; Erkan E; Shapiro R
    Transplantation; 2008 Dec; 86(12):1725-31. PubMed ID: 19104412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy.
    McCurry KR; Iacono A; Zeevi A; Yousem S; Girnita A; Husain S; Zaldonis D; Johnson B; Hattler BG; Starzl TE
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):528-37. PubMed ID: 16077423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.
    Shapiro R; Jordan ML; Basu A; Scantlebury V; Potdar S; Tan HP; Gray EA; Randhawa PS; Murase N; Zeevi A; Demetris AJ; Woodward J; Marcos A; Fung JJ; Starzl TE
    Ann Surg; 2003 Oct; 238(4):520-5; discussion 525-7. PubMed ID: 14530723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation.
    Thomas PG; Woodside KJ; Lappin JA; Vaidya S; Rajaraman S; Gugliuzza KK
    Transplantation; 2007 Jun; 83(11):1509-12. PubMed ID: 17565326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of acute cellular rejection after renal transplantation with Campath-1H.
    Basu A; Ramkumar M; Tan HP; Khan A; McCauley J; Marcos A; Fung JJ; Starzl TE; Shapiro R
    Transplant Proc; 2005 Mar; 37(2):923-6. PubMed ID: 15848576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation achievements in Mongolia.
    Jambaljav L; Nyamsuren D; Byambadash B; Ganbold L
    Transplant Proc; 2010 Apr; 42(3):791-2. PubMed ID: 20430173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
    Tan HP; Kaczorowski DJ; Basu A; Khan A; McCauley J; Marcos A; Fung JJ; Starzl TE; Shapiro R
    Transplantation; 2004 Dec; 78(11):1683-8. PubMed ID: 15591960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campath-1H (alemtuzumab) as an induction agent for the prevention of graft rejection and preservation of renal function in kidney transplant patients: Philippine 3-year follow-up.
    Muñoz AS; Cabanayan-Casasola CB; Danguilan RA; Padua FB; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2230-3. PubMed ID: 18790200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - long-term results.
    Kaufman DB; Leventhal JR; Gallon LG; Parker MA
    Am J Transplant; 2006 Feb; 6(2):331-9. PubMed ID: 16426317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alemtuzumab induction in deceased donor kidney transplantation.
    Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
    Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campath induction for kidney transplantation: report of 297 cases.
    Ortiz J; Palma-Vargas J; Wright F; Bingaman A; Agha I; Rosenblatt S; Foster P
    Transplantation; 2008 Jun; 85(11):1550-6. PubMed ID: 18551058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with Alemtuzumab (Campath-1H) as induction agent in renal transplantation followed by steroid-free immunosuppression.
    Baez Y; Giron F; Niño-Murcia A; Rodríguez J; Salcedo S
    Transplant Proc; 2008 Apr; 40(3):697-9. PubMed ID: 18454990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up.
    Tan HP; Donaldson J; Basu A; Unruh M; Randhawa P; Sharma V; Morgan C; McCauley J; Wu C; Shah N; Zeevi A; Shapiro R
    Am J Transplant; 2009 Feb; 9(2):355-66. PubMed ID: 19120078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
    Lü TM; Yang SL; Wu WZ; Tan JM
    Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation.
    Shapiro R; Ellis D; Tan HP; Moritz ML; Basu A; Vats AN; Khan AS; Gray EA; Zeevi A; McFeaters C; James G; Jo Grosso M; Marcos A; Starzl TE
    J Pediatr; 2006 Jun; 148(6):813-8. PubMed ID: 16769394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alemtuzumab induction with tacrolimus monotherapy in de novo renal transplantation.
    Villanueva ME; Muñoz AS; Casasola CC; Africa JB; Danguilan RA; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2222-5. PubMed ID: 18790198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alemtuzumab versus interleukin-2 receptor antibodies induction in living donor kidney transplantation.
    Sampaio MS; Kadiyala A; Gill J; Bunnapradist S
    Transplantation; 2009 Oct; 88(7):904-10. PubMed ID: 19935462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithymocyte globulin induction in living donor renal transplant recipients: final report of the TAILOR registry.
    Gaber AO; Matas AJ; Henry ML; Brennan DC; Stevens RB; Kapur S; Ilsley JN; Kistler KD; Cosimi AB;
    Transplantation; 2012 Aug; 94(4):331-7. PubMed ID: 22850297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.
    Farney AC; Doares W; Rogers J; Singh R; Hartmann E; Hart L; Ashcraft E; Reeves-Daniels A; Gautreaux M; Iskandar SS; Moore P; Adams PL; Stratta RJ
    Transplantation; 2009 Sep; 88(6):810-9. PubMed ID: 19920781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.